GSK3B and hepatocellular carcinoma: Our research here demonstrated that bufalin inhibited the phosphorylation of AKT, which in turn inhibited cell proliferation, migration, and invasion in the two hepatoma cell lines, and revealed that bufalin was able to suppress the phosphorylation of GSK3β (Ser 9) and increase the activated form of GSK3β.